The US Food and Drug Administration directed GlaxoSmithKline t

India's Orchid Chemicals & Pharmaceuticals Ltd has announced that it has received approv

New Delhi: Industry body FICCI has stated that trade between India and S

Rockville: The FDA will assemble a public trial by next month to think about formalizing a dispensing g

As per views of Technical Analysts, Ranbaxy Labs is looking very fairly valued at current market price. The stock ended at 433.10 levels on Friday, down by Rs 9.20 or 2.08%.